Real‐world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyureaAlberto Álvarez‐Larrán, Beatríz Bellosillo, Eduardo Arellano‐Rodrigo et al.|Cancer|2022Cited by 32
Oxidative Stress in CML Stem and Progenitor Cells Correlates with Response to ImatinibSantiago Del Castillo, Gemma Ramírez, Regina García et al.|Blood|2010Cited by 0
Validation of a New Flow Cytometry-Based Method to Discriminate Malignant From Normal Stem Cells In CMLSantiago Del Castillo, Gemma Ramírez, Regina García et al.|Blood|2010Cited by 0